about
FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects.From Homo sapiens to Homo in nexu (connected man): could functional imaging redefine the brain of a "new human species"?PET/CT WITH 68Ga-PSMA IN PROSTATE CANCER: RADIOPHARMACEUTICAL BACKGROUND AND CLINICAL IMPLICATIONS.11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.Performance comparison of two resolution modeling PET reconstruction algorithms in terms of physical figures of merit used in quantitative imaging.Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.Parametric MR dynamic imaging for breast lesions characterization and prediction of lymph nodes involvement.Perspectives on PET/MR imaging: are we ready for clinical use?Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancer[68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/mlLongitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical depositionAmyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patientsThe brain cognitive reserve hypothesis: A review with emphasis on the contribution of nuclear medicine neuroimaging techniquesToward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
P50
Q40996953-C766DB5D-70A4-4294-9976-B070091FA157Q46905130-4D032FB4-EAA0-43AA-B92B-0811788C4066Q47866062-4B7E984A-594A-49CD-A290-9AA1036AC9BDQ49967864-FA6627ED-4E4C-4F15-9ADA-B6755BDD57E0Q50913324-BD812531-2B98-416A-8E61-1B093377A63DQ52956728-1302DE85-A098-45A8-8A64-8C5D9F2821A0Q52985771-706C1180-744A-4817-8B4D-ED1FC6FB2EAEQ53041710-FC670062-DEA5-4126-92AC-5A2DEE32673EQ53078486-09EA20F2-2E19-4785-A8E2-9F7178068E7AQ90212112-22276BFB-409F-40D0-A2EB-B90AF0763D27Q90421580-E3A2BA19-101D-434B-9A90-BF10D1516CF6Q90993157-9DDF86CC-60C7-430D-A873-BE56D5CC79C0Q91538984-12B38451-1ED5-4ECD-A10E-CD5217A0B55BQ91657138-D229D76C-8F9B-42D1-A129-437282D0EB88Q91734442-7B10E014-7167-4E1F-A5D8-3F68690E04A2Q92292498-92C688CB-C4FA-4C75-8F9C-EC24C9C5F7B0
P50
description
researcher
@en
wetenschapper
@nl
name
Andrea Ciarmiello
@en
Andrea Ciarmiello
@nl
type
label
Andrea Ciarmiello
@en
Andrea Ciarmiello
@nl
prefLabel
Andrea Ciarmiello
@en
Andrea Ciarmiello
@nl
P31
P496
0000-0002-6579-656X